WILMARIE MONTERO-NEGRON: Open Payments
NPI 1548965262 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 32 payments from 12 companies in 2025. Trend: 2023 $165 · 2024 $736 · 2025 $722
Food & beverage: $610Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $153 |
| Neurocrine BioSciences, Inc. | 4 | $91 |
| Janssen Pharmaceuticals, Inc | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Lundbeck LLC | 3 | $49 |
| ABBVIE INC. | 3 | $47 |
| Alkermes, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
Products named: INGREZZA, REXULTI, Jornay PM, SPRAVATO, COBENFY, VRAYLAR, ARISTADA, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
